INHIBITEURS DE DIACYLGLYCÉROL ACYLTRANSFÉRASE POUR LE TRAITEMENT DE TROUBLES MÉTABOLIQUES OU ANALOGUES
- 专利权人:
- Pfizer Inc.
- 发明人:
- 申请号:
- EP15710006.6
- 公开号:
- EP3119757B1
- 申请日:
- 2015.03.03
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要:
- Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC AND RELATED DISORDERS
- INHIBITEURS DE DIACYLGLYCEROL ACYLTRANSFERASE POUR LE TRAITEMENT DE TROUBLES METABOLIQUES OU ANALOGUES
- INHIBITORS DIACYLGLYCERINACYLTRANSFERASE 2
- DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC AND RELATED DISORDERS
- DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC AND RELATED DISORDERS